Enzalutamide plus leuprolide reduces the risk of death by more than 40% in biochemically recurrent prostate cancer compared to leuprolide alone.

Grape seed extract—a dietary supplement made from the seeds of wine grapes—has been investigated to see if it can help reduce ...

Scott Tagawa, MD, highlights the PSMAddition trial's promising results, showcasing Lutetium-177 PSMA-617's significant ...

The Vision Vitamin That Can Blind Your Liver Everyone knows vitamin A helps with night vision, but few realize it can become ...

New data presented at the American Urological Association (AUA) annual meeting further supported the use of darolutamide (Nubeqa) in combination with androgen deprivation therapy (ADT) for patients ...

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor growth and slow symptom advance.

The researchers enrolled 92 men with recurring prostate cancer into the trial. Half received radiation alone, while the other half received the new drug plus radiation. The men who received both ...

Background: Rezvilutamide combined with androgen deprivation therapy (ADT) has become a first-line standard regimen for high-volume metastatic hormone-sensitive prostate cancer (mHSPC), but real-world ...

The supplemental catalog for the Ocala Breeders' Sales Company's October Yearling Sale is now available online at obssales.com. A total of 48 horses have been supplemented to the auction taking place ...

Prostate cancer is among the most common cancers affecting older men. But a diagnosis today isn’t always what it seems. And surgery and radiation aren’t the only options ...